Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Molecules ; 28(1)2022 Dec 21.
Artigo em Inglês | MEDLINE | ID: mdl-36615228

RESUMO

Ornamental plants often gain relevance not only for their decorative use, but also as a source of phytochemicals with interesting healing properties. Herein, spontaneous Centranthus ruber (L.) DC. and Tropaeolum majus L., mainly used as ornamental species but also traditionally consumed and used in popular medicine, were investigated. The aerial parts were extracted with methanol trough maceration, and resultant crude extracts were partitioned using solvents with increasing polarity. As previous studies mostly dealt with the phenolic content of these species, the phytochemical investigation mainly focused on nonpolar constituents, detected with GC-MS. The total phenolic and flavonoid content was also verified, and HPTLC analyses were performed. In order to explore the potential antiarthritic and anti-obesity properties, extracts and their fractions were evaluated for their anti-denaturation effects, with the use of the BSA assay, and for their ability to inhibit pancreatic lipase. The antioxidant properties and the inhibitory activity on the NO production were verified, as well. Almost all the extracts and fractions demonstrated good inhibitory effects on NO production. The n-hexane and dichloromethane fractions from T. majus, as well as the n-hexane fraction from C. ruber, were effective in protecting the protein from heat-induced denaturation (IC50 = 154.0 ± 1.9, 270.8 ± 2.3 and 450.1 ± 15.5 µg/mL, respectively). The dichloromethane fractions from both raw extracts were also effective in inhibiting pancreatic lipase, with IC50 values equal to 2.23 ± 0.02 mg/mL (for C. ruber sample), and 2.05 ± 0.02 mg/mL (T. majus). Obtained results support the traditional use of these species for their beneficial health properties and suggest that investigated plant species could be potential sources of novel antiarthritic and anti-obesity agents.


Assuntos
Fármacos Antiobesidade , Antioxidantes , Pancrelipase , Compostos Fitoquímicos , Extratos Vegetais , Tropaeolum , Valerianaceae , Antioxidantes/química , Antioxidantes/isolamento & purificação , Antioxidantes/farmacologia , Cloreto de Metileno , Compostos Fitoquímicos/química , Compostos Fitoquímicos/isolamento & purificação , Compostos Fitoquímicos/farmacologia , Extratos Vegetais/farmacologia , Extratos Vegetais/química , Tropaeolum/química , Valerianaceae/química , Pancrelipase/antagonistas & inibidores , Pancrelipase/química , Desnaturação Proteica/efeitos dos fármacos , Fármacos Antiobesidade/química , Fármacos Antiobesidade/isolamento & purificação , Fármacos Antiobesidade/farmacologia
2.
Int J Biol Macromol ; 192: 452-460, 2021 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-34634334

RESUMO

Pancreatic lipase (PL) is a key enzyme related to the prevention and treatment of obesity. The aim of the study was to evaluate the inhibitory effects of mulberry leaf polysaccharides (MLP) on PL and possible interaction mechanism, inhibition on lipid accumulation in vitro and in vivo. The results revealed that MLP had obvious inhibitory effects on PL (P < 0.05). The interaction of MLP-PL complexes was in a spontaneous way driven by enthalpy, and hydrogen bonds were the main factors in the binding. MLP could significantly inhibit the development of lipid accumulation in HepG2 cells (P < 0.05). Furthermore, consumption of high-fat diet containing MLP showed protective effects on liver and adipose tissue damages in mice, and inhibited the lipid absorption in digestive tract. MLP also significantly reduced the increased expression level of pancreatic digestive enzymes (P < 0.05). The study indicated that the anti-obesity effect of MLP might be caused by inhibition of lipid absorption via reducing PL activity.


Assuntos
Inibidores Enzimáticos/farmacologia , Morus/química , Pancrelipase/antagonistas & inibidores , Extratos Vegetais/farmacologia , Polissacarídeos/farmacologia , Tecido Adiposo , Animais , Dieta Hiperlipídica , Ativação Enzimática/efeitos dos fármacos , Inibidores Enzimáticos/química , Humanos , Metabolismo dos Lipídeos , Fígado/efeitos dos fármacos , Fígado/metabolismo , Camundongos , Peso Molecular , Obesidade , Pancrelipase/química , Extratos Vegetais/química , Folhas de Planta/química , Polissacarídeos/química , Análise Espectral
3.
Int J Biol Macromol ; 150: 31-37, 2020 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-32035149

RESUMO

The inhibitory activity of taxifolin on three digestive enzymes were investigated in both vitro and vivo. Taxifolin exhibited inhibitory effect on α-glucosidase, α-amylase and pancreatic lipase with IC50 values of 0.038, 0.647 and 0.993 mg/mL, respectively. Inhibitory kinetics indicated that taxifolin was more like a competitive inhibitor of α-glucosidase and α-amylase, while it was a non-competitive inhibitor of pancreatic lipase. The binding of taxifolin caused the quenching of intrinsic fluorescence intensity of enzymes, and the binding constant (lgKa) and the number of binding site (n) were further calculated through fluorescence titration. The values of lgKa were in the range of 4.93-6.65, and the values of n were all close to 1. Molecular docking indicated that taxifolin could interact with α-glucosidase and α-amylase through many kinds of secondary interaction, such as hydrogen bond, π-π stack, etc. In vivo study revealed that pre-administration with taxifolin can significantly improve the postprandial hyperglycemia in rat. Furthermore, its can also decrease triglyceride absorption through the inhibition of pancreatic lipase.


Assuntos
Inibidores Enzimáticos/farmacologia , Quercetina/análogos & derivados , Animais , Ativação Enzimática/efeitos dos fármacos , Inibidores Enzimáticos/química , Feminino , Glucose/metabolismo , Inibidores de Glicosídeo Hidrolases/química , Inibidores de Glicosídeo Hidrolases/farmacologia , Cinética , Metabolismo dos Lipídeos/efeitos dos fármacos , Simulação de Acoplamento Molecular , Simulação de Dinâmica Molecular , Pancrelipase/antagonistas & inibidores , Pancrelipase/química , Quercetina/química , Quercetina/farmacologia , Ratos , Relação Estrutura-Atividade , alfa-Amilases/antagonistas & inibidores , alfa-Amilases/química , alfa-Amilases/metabolismo , alfa-Glucosidases/química
4.
Molecules ; 24(19)2019 Sep 29.
Artigo em Inglês | MEDLINE | ID: mdl-31569521

RESUMO

A novel lipid inhibition peptide Leu-Leu-Val-Val-Try-Pro-Trp-Thr-Gln-Arg (PP1) (MW 1274.53 Da) was obtained from Chlorella pyenoidose using enzymatic hydrolysis, gel filtration chromatography, and LC-MS/MS. Its lipid inhibition effects indicated that the synthetic peptide PP1 exhibits a good inhibitory effect against porcine pancreatic lipase (PL) (47.95%) at 200 µg/mL, which could be attributed to its hydrogen binding into catalytic sites of PL (Ser153, Asp177, and His 264) by docking analysis. Furthermore, in 3T3-L1 cells, the synthetic PP1 remarkedly decreased the accumulation of intracellular triacylglycerol (27.9%, 600 µg/mL), which carried a similar consequence as the positive drug simvastatin (24.1%, 10 µM). Western blot revealed that PP1 inhibited the lipid accumulation and fatty acid synthesis in 3T3-L1 adipocytes in two pathways, primarily: nonalcoholic fatty liver disease (NAFLD) pathway (C/EBPα, SREBP-1c, AMPKα) and AMPK signaling pathway (SREBP-1c, PPARγ, AMPKα). In short, these results support that PP1 can be used as a potential agent against obesity.


Assuntos
Chlorella/química , Oligopeptídeos/química , Oligopeptídeos/farmacologia , Células 3T3-L1 , Sequência de Aminoácidos , Animais , Fracionamento Químico , Relação Dose-Resposta a Droga , Hidrólise , Camundongos , Modelos Moleculares , Peso Molecular , Oligopeptídeos/isolamento & purificação , Pancrelipase/antagonistas & inibidores , Pancrelipase/química , Extratos Vegetais/química , Extratos Vegetais/isolamento & purificação , Extratos Vegetais/farmacologia , Conformação Proteica , Suínos
5.
Asian Pac J Cancer Prev ; 20(8): 2503-2514, 2019 08 01.
Artigo em Inglês | MEDLINE | ID: mdl-31450926

RESUMO

Paramount efforts by pharmaceutical industry to identify new targets for obesity-diabetes (Diabesity) pharmacological intervention have led to a number of agents developed and directed at DPP IV [dipeptidyl peptidase IV] enzyme inhibition thereby enhancing endogenous insulinotropic incretins. Besides antioxidative-antiinflammtory molecules that inhibit accumulation of advanced glycation end products (AGEs) can be good candidates for ameliorating diabetic complications. Fluoroquinolones (FQs) have been identified recently as potent inhibitors of pancreatic lipase (PL). The suggested association between obesity and colorectal cancer initiated the evaluation of antiproliferative activity of the new FQs and TFQs against a panel of obesity related colorectal cells (HT29, HCT116, SW620 CACO2 and SW480). The aim of the current study is to examine the potential of newly synthesized FQs and triazolofluoroquinolones (TFQs) derivatives as dual inhibitors for glycation and inflammation, DPP IV inhibitors, PL inhibitors for dual management of obesity and diabetes, as well as antiprolifertaive efficacy against colorectal cancer cell lines. Sulforodamine B (SRB) colorimetric assay revealed that some derivatives exhibited unselective cytotoxity against HT29, HCT116, SW620 CACO2 and SW480. The superior antiglycation activity of the reduced derivatives 4a and 4b over that of aminoguanidine with respective IC50 (µM) values of 3.05±0.33 and 8.51±3.21; none of the tested synthetic compounds could perform equally effectively to Diprotin A, a dose dependent inhibitor of DPP IV. Compounds 4a, 5a, 3b, 4b and 5b demonstrated anti-inflammatory IC50 values exceeding that of indomethacin. Compounds 3a and 4a showed IC50 lower than 10 µM as PL inhibitors. In conclusion, FQ and TFQ derivatives may unveil new antiobesity and anticancer agents in the future. Our research qualifies FQs and TFQs as promising candidates for the development of related α-dicarbonyl scavengers as therapeutic agents to protect cells against carbonyl stress.


Assuntos
Anti-Inflamatórios/farmacologia , Antineoplásicos/farmacologia , Dipeptidil Peptidase 4/química , Inibidores da Dipeptidil Peptidase IV/farmacologia , Fluoroquinolonas/farmacologia , Glicosilação/efeitos dos fármacos , Pancrelipase/antagonistas & inibidores , Animais , Anti-Inflamatórios/química , Antineoplásicos/química , Sítios de Ligação , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Inibidores da Dipeptidil Peptidase IV/química , Inibidores Enzimáticos/química , Inibidores Enzimáticos/farmacologia , Fluoroquinolonas/química , Inflamação/tratamento farmacológico , Concentração Inibidora 50 , Macrófagos/efeitos dos fármacos , Camundongos , Simulação de Acoplamento Molecular
6.
Chem Biol Drug Des ; 90(6): 1282-1294, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-28639358

RESUMO

Fluoroquinolones (FQs) have been identified recently as potent inhibitors of pancreatic lipase (PL). The aim of this study was to synthesize novel FQs and triazolofluoroquinolones (TFQs) and to evaluate them in vitro with respect to their antilipolytic efficacy and potency properties. The PL-IC50 values of 12 FQs and TFQs (3 (a-c)-6 (a-c)) were in the range of 12.5-189.1 µm. These values are further supported by docking studies. The suggested association between obesity and colorectal cancer initiated the evaluation of antiproliferative activity of the new FQs and TFQs against a panel of obesity-related colorectal cells (HT29, HCT116, SW620 CACO2, and SW480). Sulforodamine B colorimetric assay revealed that some derivatives exhibited unselective cytotoxicity against HT29, HCT116, SW620 CACO2, and SW480. Remarkably, FQ 4a's selective cytotoxicity against HCT116 was found valuable with IC50 value of 4.2 µm which exceeds that of cisplatin with a substantial selective cytotoxicity in periodontal ligament fibroblasts. In conclusion, FQ and TFQ derivatives may unveil new antiobesity and anticancer agents in the future.


Assuntos
Antineoplásicos/química , Fluoroquinolonas/química , Pancrelipase/antagonistas & inibidores , Antineoplásicos/síntese química , Antineoplásicos/farmacologia , Sítios de Ligação , Células CACO-2 , Domínio Catalítico , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Fluoroquinolonas/síntese química , Fluoroquinolonas/farmacologia , Humanos , Ligação de Hidrogênio , Concentração Inibidora 50 , Simulação de Acoplamento Molecular , Pancrelipase/metabolismo , Relação Estrutura-Atividade , Termodinâmica
7.
J Sci Food Agric ; 96(14): 4713-4723, 2016 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26970531

RESUMO

BACKGROUND: The phytotherapic treatment of overweight and/or moderate obesity is growing widely, thus there is a great interest towards the phenolic compounds of fruits and vegetables which may inhibit pancreatic lipase enzyme. In this study, we report the chemical composition and in vitro pancreatic lipase inhibitory activity of 13 freeze-dried anthocyanin-containing extracts of different Mediterranean plants: fruits (blood orange, pomegranate, blackberry, mulberry and sumac), citrus by-products (blood orange peel), citrus vegetative tissues (young lemon shoots); vegetables (red cabbage and violet cauliflower), legume seeds (black bean), cereals (black rice), and cereal processing by-products (black rice hull). Total phenols and anthocyanins were determined. Individual anthocyanins were identified by UHPLC-PDA-ESI/MSn . RESULTS: Results revealed a wide variation in the distribution of anthocyanin compounds. Blood orange and pomegranate juice extracts had the highest total anthocyanin content and exhibited the strongest inhibition of pancreatic lipase in vitro. CONCLUSION: Inhibitory activity was positively correlated with anthocyanin content. In appropriate formulations, anthocyanin-containing extracts could find a use as anti-obesity agents. © 2016 Society of Chemical Industry.


Assuntos
Antocianinas/química , Fabaceae/química , Frutas/química , Pancrelipase/antagonistas & inibidores , Extratos Vegetais/farmacologia , Verduras/química , Antocianinas/genética , Antocianinas/metabolismo , Grão Comestível/química , Extratos Vegetais/química
8.
Nat Prod Res ; 30(5): 583-9, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-25868614

RESUMO

Effect of aqueous methanol extract of different colour sweet bell peppers (Capsicum annuum L.) on parameters of diabesity and carbonyl stress was analysed in vitro. Yellow pepper displayed significantly (p < 0.001) higher intestinal α-glucosidase inhibitory activity than green and red pepper. Porcine pancreatic lipase inhibitory activity was significantly (p < 0.01) high in yellow and red pepper than in green pepper. Green and red pepper inhibited vesperlysine-type advanced glycation end products (AGEs) more potently than yellow pepper; however, pentosidine-type AGEs were similarly inhibited by all three peppers. Yellow and red pepper inhibited lipid peroxidation more potently (p < 0.01) than green pepper. Total polyphenol content and free radicals scavenging activities in yellow and red bell peppers were higher than in green pepper. Total flavonoid content was high in green pepper than that present in yellow and red peppers. Green pepper displayed presence of proanthocyanins; however, oligomeric anthocyanins were detected in yellow and red peppers.


Assuntos
Capsicum/química , Glicolipídeos/sangue , Hipolipemiantes/farmacologia , Extratos Vegetais/farmacologia , Carbonilação Proteica/efeitos dos fármacos , Animais , Cor , Sequestradores de Radicais Livres/farmacologia , Produtos Finais de Glicação Avançada/antagonistas & inibidores , Glicolipídeos/antagonistas & inibidores , Peroxidação de Lipídeos/efeitos dos fármacos , Pancrelipase/antagonistas & inibidores , Polifenóis/análise , Suínos
9.
Molecules ; 18(9): 10629-38, 2013 Sep 02.
Artigo em Inglês | MEDLINE | ID: mdl-24002138

RESUMO

Activity-guided isolation of a methanolic extract of Galla Rhois using pancreatic lipase and 3T3-L1 adipocytes led to the isolation of seven phenolic compounds: protoaphin-fb (1), 2-O-digalloyl-1,3,4,6-tetra-O-galloyl-ß-D-glucose (2), 1,2,3,4,6-penta-O-galloyl-ß-D-glucose (3), 1,2,4,6-tetra-O-galloyl-ß-D-glucose (4), 3-hydroxy-5-methoxy-phenol 1-O-ß-D-glucoside (5), methylgallate (6), and gallic acid (7). Their structures were established on the basis of NMR and MS spectroscopic data interpretation. All isolates were evaluated for their inhibitory effects on pancreatic lipase, and compounds 1-5 exhibited potent inhibitory effects on this enzyme, with IC50 values ranging from 30.6 ± 2.4 to 3.5 ± 0.5 mM. In addition, the highly galloylated compound 2 was also found to induce potent inhibition of adipocyte differentiation in 3T3-L1 cells.


Assuntos
Adipócitos/fisiologia , Diferenciação Celular/efeitos dos fármacos , Taninos Hidrolisáveis/farmacologia , Pancrelipase/antagonistas & inibidores , Extratos Vegetais/farmacologia , Rhus/química , Células 3T3-L1 , Adipócitos/efeitos dos fármacos , Animais , Inibidores Enzimáticos/química , Inibidores Enzimáticos/isolamento & purificação , Inibidores Enzimáticos/farmacologia , Taninos Hidrolisáveis/química , Medicina Tradicional Coreana , Camundongos , Pancrelipase/química , Extratos Vegetais/química , Extratos Vegetais/isolamento & purificação , Tumores de Planta
10.
Molecules ; 17(6): 6237-48, 2012 May 25.
Artigo em Inglês | MEDLINE | ID: mdl-22634836

RESUMO

Oxidation of low-density lipoprotein (LDL) is the principal risk factor for the development of atherosclerosis. In this study, we used several methods to investigate the ability of the acetone extract from rhizomes, stems, leaves, flowers, pericarps and seeds of Alpinia zerumbet to inhibit atherosclerosis in vitro. The seed extract had the strongest activity against tyrosinase, pancreatic lipase (PL), 15-lipoxygenase (15-LO) and LDL oxidation activities (IC50 = 2.30 ± 0.02, 5.00 ± 0.07, 1.29 ± 0.07 and 15.40 ± 0.86 µg/mL, respectively), amongst all different parts. It also had similar effects to the positive controls. Most of the extracts showed partial agonistic properties towards estrogenic activity. Cholest-4-ene-3,6-dione, a steroid present only in the seed extract seems to be the compound responsible for these activities. The results showed that cholest-4-ene-3,6-dione had similar ability to curcumin and quercetin against PL and LDL oxidation (IC50 = 19.50 ± 1.17 and 16.12 ± 1.43 µg/mL, respectively). Furthermore, cholest-4-ene-3,6-dione (IC50 = 34.21 ± 1.31 µg/mL) had higher inhibition against 15-LO than quercetin (IC50 = 54.79 ± 1.12 µg/mL).


Assuntos
Alpinia/química , Antioxidantes/farmacologia , Inibidores Enzimáticos/farmacologia , Extratos Vegetais/farmacologia , Sementes/química , Acetona/química , Antioxidantes/química , Aterosclerose/tratamento farmacológico , Relação Dose-Resposta a Droga , Inibidores Enzimáticos/química , Cromatografia Gasosa-Espectrometria de Massas , Humanos , Concentração Inibidora 50 , Lipoproteínas LDL/metabolismo , Inibidores de Lipoxigenase/química , Inibidores de Lipoxigenase/farmacologia , Monofenol Mono-Oxigenase/antagonistas & inibidores , Oxirredução/efeitos dos fármacos , Pancrelipase/antagonistas & inibidores , Extratos Vegetais/química , Solventes/química
11.
Fitoterapia ; 82(2): 212-8, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20923698

RESUMO

An aqueous ethanol extract of Bergenia crassifolia rhizomes strongly inhibited human pancreatic lipase activity and increased scavenging of DPPH free radicals in vitro. Chromatographic separation of this extract led to isolation of the hydrolysable tannins (+)-catechin 3,5-di-O-gallate (1) and (+)-catechin 3-O-gallate (2). This is the first report of the isolation of compound 1 from plant material. This compound strongly inhibited human pancreatic lipase (with an IC(50) value of 0.42 µg/ml) and exhibited a remarkable free radical-scavenging ability (with an SC(50) value of 1.04 µg/ml). The chemical structures of 1 and 2 were elucidated using MS, NMR and chemical approaches.


Assuntos
Antioxidantes/farmacologia , Catequina/farmacologia , Inibidores Enzimáticos/farmacologia , Pancrelipase/antagonistas & inibidores , Extratos Vegetais/farmacologia , Saxifragaceae/química , Antioxidantes/isolamento & purificação , Compostos de Bifenilo/metabolismo , Catequina/análogos & derivados , Catequina/isolamento & purificação , Inibidores Enzimáticos/isolamento & purificação , Humanos , Concentração Inibidora 50 , Pâncreas , Picratos/metabolismo , Extratos Vegetais/química , Rizoma
12.
Horm Metab Res ; 40(8): 539-43, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18500680

RESUMO

Cetilistat is a novel inhibitor of pancreatic lipase. The aim of this report is to evaluate the anti-obesity action of cetilistat in diet-induced obesity (DIO) rats. Cetilistat inhibited rat and human pancreatic lipase activity with an IC (50) of 54.8 nmol/l, and 5.95 nmol/l, respectively, meaning that it is 9.2 times more potent for human pancreatic lipase than for that of rat. Cetilistat was orally administered simultaneously with fat emulsion to Sprague-Dawley rats. Plasma triglyceride (TG) concentrations were measured before and after oral fat loading. The elevation in plasma triglyceride concentration by oral fat loading was reduced by cetilistat in a dose-dependent manner at 3, 10, 30, and 100 mg/kg, indicating that cetilistat reduces intestinal fat absorption in rats. Cetilistat was administered to DIO F344 rats as food admixture in a high-fat diet at 4.9, 14.9, or 50.7 mg/kg/day for three weeks. Both triglyceride and nonesterified fatty acid content in the feces were dose-dependently and drastically increased, suggesting the intestinal breakdown of fat and excretion. Body weight (BW) gain and white adipose tissue (WAT) weight were reduced in a dose-dependent manner. In addition, leptin, TG, and total cholesterol (TC) in plasma were reduced and there were no reports of oily stools. These results suggest that cetilistat ameliorates obesity and hyperlipidemia in DIO rats, a plausible animal model of the most common type of human obesity.


Assuntos
Fármacos Antiobesidade , Benzoxazinas/farmacologia , Inibidores Enzimáticos/farmacologia , Metabolismo dos Lipídeos/efeitos dos fármacos , Obesidade/tratamento farmacológico , Pâncreas/enzimologia , Pancrelipase/antagonistas & inibidores , Aumento de Peso/efeitos dos fármacos , Tecido Adiposo/efeitos dos fármacos , Tecido Adiposo/metabolismo , Animais , Colesterol/sangue , Dieta , Gorduras na Dieta/farmacologia , Relação Dose-Resposta a Droga , Fezes/química , Masculino , Obesidade/etiologia , Pâncreas/efeitos dos fármacos , Ratos , Ratos Endogâmicos F344 , Triglicerídeos/sangue
13.
Life Sci ; 82(21-22): 1045-9, 2008 May 23.
Artigo em Inglês | MEDLINE | ID: mdl-18433791

RESUMO

In many traditional schools of medicine it is claimed that a balanced modulation of several targets can provide a superior therapeutic effect and decrease in side effect profile compared to a single action from a single selective ligand, especially in the treatment of certain chronic and complex diseases, such as diabetes and obesity. Diabetes and obesity have a multi-factorial basis involving both genetic and environmental risk factors. A wide array of medicinal plants and their active constituents play a role in the prevention and treatment of diabetes. Salacia roots have been used in Ayurvedic medicine for diabetes and obesity since antiquity, and have been extensively consumed in Japan, the United States and other countries as a food supplement for the prevention of obesity and diabetes. Recent pharmacological studies have demonstrated that Salacia roots modulate multiple targets: peroxisome proliferator-activated receptor-alpha-mediated lipogenic gene transcription, angiotensin II/angiotensin II type 1 receptor, alpha-glucosidase, aldose reductase and pancreatic lipase. These multi-target actions may mainly contribute to Salacia root-induced improvement of type 2 diabetes and obesity-associated hyperglycemia, dyslipidemia and related cardiovascular complications seen in humans and rodents. The results of bioassay-guided identification indicate that mangiferin, salacinol, kotalanol and kotalagenin 16-acetate are at least in part responsible for these multi-target regulatory activities of Salacia roots. The evidence suggests that this unique traditional medicine fulfills a multiple-target strategy in the prevention and treatment of diabetes and obesity. Although toxicological studies have suggested minimal adverse effects of the herbal medicine in rodents, a clinical trial is crucial to further confirm the safety of Salacia roots. In addition, further mechanistic studies are necessary in order to allow a better understanding of how use of Salacia root may interact with other therapeutic interventions.


Assuntos
Diabetes Mellitus/tratamento farmacológico , Ayurveda , Obesidade/tratamento farmacológico , Fitoterapia , Salacia/química , Aldeído Redutase/antagonistas & inibidores , Bloqueadores do Receptor Tipo 1 de Angiotensina II/farmacologia , Animais , Ácidos Graxos/metabolismo , Inibidores de Glicosídeo Hidrolases , Humanos , Miocárdio/metabolismo , PPAR alfa/agonistas , Pancrelipase/antagonistas & inibidores , Raízes de Plantas/química , Receptor Tipo 1 de Angiotensina/efeitos dos fármacos , Receptor Tipo 1 de Angiotensina/fisiologia , Transdução de Sinais
14.
J Pharm Biomed Anal ; 41(5): 1657-65, 2006 Aug 28.
Artigo em Inglês | MEDLINE | ID: mdl-16621416

RESUMO

Natural seeds of Japanese horse chestnut (Aesculus turbinata Blume) contain large amounts of mixed triterpenoidal saponins called escins. Recent studies have shown that escins have several biological activities including anti-inflammatory action and inhibitory effects on the absorption of ethanol and glucose. For the edible utilization of the seeds, natural seeds are usually treated with wooden ashes to remove harshness. Here, we found the novel compounds derived from escins in the edible seeds after the food processing with wooden ashes. The instrumental analyses revealed the chemical structures of escins and the derivatives. These compounds are identified as four types of deacetylescins Ia, IIa, Ib, and IIb as well as two types of desacylescins I and II. To determine their biological activity, the purified compounds were tested for their potential nutraceutical activity. The oral glucose tolerance test in mice revealed that a single oral administration of the isolated components of deacetylescins at a dose of 100 mg/kg was clearly effective in attenuating the elevation of blood glucose levels. The inhibitory effects of escins and their derivatives were in the order of escins>deacetylescins>desacylescins. Moreover, we found the inhibitory activity of those compounds on pancreatic lipase. Escins were the most potent in inhibiting the enzyme activity, and followed by desacylescins and then deacetylescins. Taken together, our results suggest the potential usefulness of novel saponins including deacetylescins and desacylescins from edible seeds as novel sources for nutraceutical foods with anti-obese effects.


Assuntos
Aesculus/química , Suplementos Nutricionais/análise , Saponinas/análise , Saponinas/farmacologia , Animais , Fármacos Antiobesidade/farmacologia , Sequência de Carboidratos , Cromatografia Líquida de Alta Pressão , Escina/análise , Escina/farmacologia , Teste de Tolerância a Glucose , Hidrólise , Hipoglicemiantes/farmacologia , Espectroscopia de Ressonância Magnética , Masculino , Camundongos , Camundongos Endogâmicos ICR , Pancrelipase/antagonistas & inibidores , Sementes/química , Espectrometria de Massas por Ionização por Electrospray , Madeira
15.
Yakugaku Zasshi ; 126(1): 43-9, 2006 Jan.
Artigo em Japonês | MEDLINE | ID: mdl-16394649

RESUMO

In the process of investigating the hypolipidemic effects of Spirulina platensis, we found that the aqueous extract of S. platensis may inhibit the intestinal absorption of dietary fat by inhibiting pancreatic lipase activity. The aqueous extract of S. platensis (500 m/kg) reduced the elevation of rat plasma triacylglycerol levels after oral administration of the lipid emulsion 2 h after administration. To clarify the hypolipidemic effects of S. platensis, the active component was isolated and designated 1'-O-(palmitonyl)-2'-O-(caprylonyl) glyceryl-beta-alpha-D-galactopyranoside (glycolipid H-b2). Glycolipid H-b2 was found to inhibit pancreatic lipase activity in a dose-dependent manner. The fractions containing glycolipid H-b2 (250 mg/kg) reduced the elevation of rat plasma triacylglycerol levels after oral administration of the lipid emulsion 2 h after administration. Furthermore, we examined the effects of phycocyanin isolated from S. platensis on pancreatic lipase activity. Phycocyanin inhibited the pancreatic lipase activity in a dose-dependent manner. These results suggest that the inhibitory effects of S. platensis on postprandial triacylglycerolemia may be due in part to the inhibition of pancreatic lipase activity by glycolipid H-b2 and phycocyanin.


Assuntos
Proteínas de Bactérias/química , Glicolipídeos/farmacologia , Hipertrigliceridemia/tratamento farmacológico , Pancrelipase/antagonistas & inibidores , Ficocianina/farmacologia , Período Pós-Prandial , Administração Oral , Animais , Relação Dose-Resposta a Droga , Feminino , Glicolipídeos/administração & dosagem , Glicolipídeos/isolamento & purificação , Masculino , Camundongos , Camundongos Endogâmicos ICR , Ficocianina/administração & dosagem , Ficocianina/isolamento & purificação , Ratos , Ratos Wistar , Spirulina
16.
Orv Hetil ; 146(11): 493-8, 2005 Mar 13.
Artigo em Húngaro | MEDLINE | ID: mdl-15813187

RESUMO

The overweight and obesity represent severe problems for the health management system of developed countries. In the evolution of obesity, beside genetic background, the environmental factors also play important roles. In the daily routine, the majority of obese patients need drug treatment, over the diet and physical activity. Among the available medicines the inhibitors of monoamine re-uptake causes dry mouth, tachycardia, sleeplessness and elevated blood pressure, therefore, due to the frequently associated obesity and hypertension many physicians avoid using these compounds. The orlistat as a selective inhibitor of pancreatic and enteral lipase enzymes impedes the absorption of the highest calorie containing nutrients, the fats exerting beneficial effects in the treatment of obesity. The abdominal bloating and diarrhea as side effects of the drug may act as an advantage in many cases, since these happen especially in those cases when the patient neglects the previously suggested low fat diet and therefore the drug induced diarrhea and bloating may mean a feed-back for the patient in respect of the proper diet. Recent studies show many beneficial biochemical changes in obesity related pathological metabolic processes during the administration of orlistat. The authors, in their present work review in short the role of orlistat in the treatment of slimming cure.


Assuntos
Fármacos Antiobesidade/uso terapêutico , Absorção Intestinal/efeitos dos fármacos , Lactonas/uso terapêutico , Lipase/antagonistas & inibidores , Obesidade/tratamento farmacológico , Fármacos Antiobesidade/efeitos adversos , Humanos , Lactonas/efeitos adversos , Obesidade/complicações , Obesidade/terapia , Orlistate , Pancrelipase/antagonistas & inibidores
17.
Arch Pharm Res ; 27(10): 1048-52, 2004 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-15554263

RESUMO

A 1, 2-diglyceride-based multi-step colorimetric assay to measure the pancreatic lipase activity was applied for the determination of the kinetic profiles of the lipase inhibition with a slight modification and the validity verification. With this assay method, our study revealed that platycodin D, one of major constituents of Platycodi Radix, inhibits the pancreatic lipase activity in a competitive type, with the value of Kl being 0.18 +/- 0.02 mM. In addition, PD has affected the values of Km,app and Kcat/Km in a dose- dependent manner. The results shed a meaningful light on how PD mediates lipid metabolism in the intestinal tracts. On the other hand, since the revised assay is sensitive, rapid, and does not affect the accuracy to the kinetic properties, it is applicable not only to evaluation of the kinetic properties of the pancreatic lipase, but also to high-throughput screening of pancreatic lipase activity.


Assuntos
Fármacos Antiobesidade/farmacologia , Inibidores Enzimáticos/farmacologia , Hipolipemiantes/farmacologia , Pancrelipase/antagonistas & inibidores , Saponinas/farmacologia , Triterpenos/farmacologia , Fármacos Antiobesidade/química , Sequência de Carboidratos , Colorimetria , Inibidores Enzimáticos/química , Hipolipemiantes/química , Indicadores e Reagentes , Cinética , Dados de Sequência Molecular , Pancrelipase/química , Reprodutibilidade dos Testes , Saponinas/química , Triterpenos/química
18.
Biol Pharm Bull ; 27(1): 138-40, 2004 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-14709919

RESUMO

A pancreatic lipase inhibitor, 5-hydroxy-7-(4'-hydroxy-3'-methoxyphenyl)-1-phenyl-3-heptanone (HPH), from the rhizome of Alpinia officinarum (AO) was isolated and its antihyperlipidemic activity was measured. HPH inhibited a pancreatic lipase with an IC(50) value of 1.5 mg/ml (triolein as a substrate). HPH significantly lowered the serum TG level in corn oil feeding-induced triglyceridemic mice, and reduced serum triglyceride (TG) and cholesterol in Triton WR-1339-induced hyperlipidemic mice. However, HPH did not show hypolipidemic activity in high cholesterol diet-induced hyperlipidemic mice. Based on these findings, we propose that PL inhibitors may be effective as hypolipidemic agents.


Assuntos
Alpinia/química , Inibidores Enzimáticos/isolamento & purificação , Inibidores Enzimáticos/farmacologia , Heptanos/isolamento & purificação , Heptanos/farmacologia , Lipídeos/sangue , Pancrelipase/antagonistas & inibidores , Animais , Colesterol/sangue , LDL-Colesterol/sangue , Óleo de Milho , Hiperlipidemias/sangue , Hiperlipidemias/induzido quimicamente , Indicadores e Reagentes , Masculino , Camundongos , Camundongos Endogâmicos ICR , Raízes de Plantas/química , Polietilenoglicóis , Triglicerídeos/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...